These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
457 related articles for article (PubMed ID: 18673427)
1. Alterations in natural killer cells and natural killer T cells during acute viral hepatitis E. Srivastava R; Aggarwal R; Bhagat MR; Chowdhury A; Naik S J Viral Hepat; 2008 Dec; 15(12):910-6. PubMed ID: 18673427 [TBL] [Abstract][Full Text] [Related]
2. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy. Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292 [TBL] [Abstract][Full Text] [Related]
3. A comparative study of immunomagnetic methods used for separation of human natural killer cells from peripheral blood. Øren A; Husebø C; Iversen AC; Austgulen R J Immunol Methods; 2005 Aug; 303(1-2):1-10. PubMed ID: 16054641 [TBL] [Abstract][Full Text] [Related]
4. Natural killer T cell deficiency in active adult-onset Still's Disease: correlation of deficiency of natural killer T cells with dysfunction of natural killer cells. Lee SJ; Cho YN; Kim TJ; Park SC; Park DJ; Jin HM; Lee SS; Kee SJ; Kim N; Yoo DH; Park YW Arthritis Rheum; 2012 Sep; 64(9):2868-77. PubMed ID: 22605480 [TBL] [Abstract][Full Text] [Related]
5. Expansion of natural killer (NK) and natural killer-like T (NKT)-cell populations derived from patients with B-chronic lymphocytic leukemia (B-CLL): a potential source for cellular immunotherapy. Guven H; Gilljam M; Chambers BJ; Ljunggren HG; Christensson B; Kimby E; Dilber MS Leukemia; 2003 Oct; 17(10):1973-80. PubMed ID: 14513047 [TBL] [Abstract][Full Text] [Related]
6. Cytotoxic T lymphocytes and natural killer cells display impaired cytotoxic functions and reduced activation in patients with alcoholic hepatitis. Støy S; Dige A; Sandahl TD; Laursen TL; Buus C; Hokland M; Vilstrup H Am J Physiol Gastrointest Liver Physiol; 2015 Feb; 308(4):G269-76. PubMed ID: 25501547 [TBL] [Abstract][Full Text] [Related]
7. Distribution of intrahepatic T, NK and CD3(+)CD56(+)NKT cells alters after liver transplantation: Shift from innate to adaptive immunity? Werner JM; Lang C; Scherer MN; Farkas SA; Geissler EK; Schlitt HJ; Hornung M Transpl Immunol; 2011 Jul; 25(1):27-33. PubMed ID: 21635950 [TBL] [Abstract][Full Text] [Related]
8. Impaired function of innate T lymphocytes and NK cells in the acute phase of ischemic stroke. Peterfalvi A; Molnar T; Banati M; Pusch G; Miko E; Bogar L; Pal J; Szereday L; Illes Z Cerebrovasc Dis; 2009; 28(5):490-8. PubMed ID: 19752550 [TBL] [Abstract][Full Text] [Related]
9. A Wilms tumor cell line, HFWT, can greatly stimulate proliferation of CD56+ human natural killer cells and their novel precursors in blood mononuclear cells. Harada H; Watanabe S; Saijo K; Ishiwata I; Ohno T Exp Hematol; 2004 Jul; 32(7):614-21. PubMed ID: 15246157 [TBL] [Abstract][Full Text] [Related]
10. Profiles of NK, NKT cell activation and cytokine production following vaccination against hepatitis B. Albarran B; Goncalves L; Salmen S; Borges L; Fields H; Soyano A; Montes H; Berrueta L APMIS; 2005; 113(7-8):526-35. PubMed ID: 16086823 [TBL] [Abstract][Full Text] [Related]
11. [Peripheral NK and NKT cell in pediatric subjects with chronic HBV infection]. Yang B; Chen LM; Ye WH; Zhang HF; Cheng Y Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Feb; 23(1):59-61. PubMed ID: 19799021 [TBL] [Abstract][Full Text] [Related]
12. Effect of cyclosporin A on interleukin-15-activated umbilical cord blood natural killer cell function. Lin SJ; Kuo ML Cytotherapy; 2008; 10(4):397-405. PubMed ID: 18574772 [TBL] [Abstract][Full Text] [Related]
13. Interleukin-2 and natural killer activity in acute type B hepatitis. Echevarria S; Casafont F; Miera M; Lozano JL; de la Cruz F; San Miguel G; Pons Romero F Hepatogastroenterology; 1991 Aug; 38(4):307-10. PubMed ID: 1937376 [TBL] [Abstract][Full Text] [Related]
14. Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure. Golden-Mason L; Madrigal-Estebas L; McGrath E; Conroy MJ; Ryan EJ; Hegarty JE; O'Farrelly C; Doherty DG Gut; 2008 Aug; 57(8):1121-8. PubMed ID: 18372499 [TBL] [Abstract][Full Text] [Related]
15. Natural killer activity in patients with acute viral hepatitis. Chemello L; Mondelli M; Bortolotti F; Schiavon E; Pontisso P; Alberti A; Rondanelli EG; Realdi G Clin Exp Immunol; 1986 Apr; 64(1):59-64. PubMed ID: 3089650 [TBL] [Abstract][Full Text] [Related]
16. High frequency of activated natural killer and natural killer T-cells in patients with new onset of type 2 diabetes mellitus. Guo H; Xu B; Gao L; Sun X; Qu X; Li X; Liu S; Feng J; Wang J; Tang Y; Yan G; Gao X; Jiang Y Exp Biol Med (Maywood); 2012 May; 237(5):556-62. PubMed ID: 22547395 [TBL] [Abstract][Full Text] [Related]
17. NK cell activation and protection occur independently of natural killer T cells during Trypanosoma cruzi infection. Duthie MS; Kahn SJ Int Immunol; 2005 May; 17(5):607-13. PubMed ID: 15802307 [TBL] [Abstract][Full Text] [Related]
18. Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections. Oliviero B; Varchetta S; Paudice E; Michelone G; Zaramella M; Mavilio D; De Filippi F; Bruno S; Mondelli MU Gastroenterology; 2009 Sep; 137(3):1151-60, 1160.e1-7. PubMed ID: 19470388 [TBL] [Abstract][Full Text] [Related]
19. Natural killer cell mediated cytotoxicity of tumor cells initiated by neem leaf preparation is associated with CD40-CD40L-mediated endogenous production of interleukin-12. Bose A; Baral R Hum Immunol; 2007 Oct; 68(10):823-31. PubMed ID: 17961770 [TBL] [Abstract][Full Text] [Related]
20. Natural killer and NK-Like T-cell activation in colorectal carcinoma patients treated with autologous tumor-derived heat shock protein 96. Pilla L; Squarcina P; Coppa J; Mazzaferro V; Huber V; Pende D; Maccalli C; Sovena G; Mariani L; Castelli C; Parmiani G; Rivoltini L Cancer Res; 2005 May; 65(9):3942-9. PubMed ID: 15867395 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]